Skip to main content
. 1999 Dec 21;96(26):14894–14898. doi: 10.1073/pnas.96.26.14894

Table 2.

Effect of treatment with GHRH antagonist JV-1-36 on tumor volume and weight in nude mice bearing xenografts of H-69 human SCLC

Treatment Initial tumor volume, mm3 Final tumor volume, mm3 Tumor burden, mg tumor wt/g body wt
Control 64.8 ± 10.1 2,254 ± 584 64.7 ± 15.1
JV-1-36 (10 μg/day) 66.1 ± 15.9 1,036 ± 337 35.7 ± 12.5
JV-1-36 (20 μg/day) 65.1 ± 12.7 461 ±  91* 17.7 ±  4.2*

*P < 0.05.